- Home
- ASBP vs NYC Comparison
ASBP vs NYC Comparison
Compare ASBP & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASBP
- NYC
- Stock Information
- Founded
- ASBP 2021
- NYC 2013
- Country
- ASBP United States
- NYC United States
- Employees
- ASBP N/A
- NYC N/A
- Industry
- ASBP Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- ASBP Health Care
- NYC Finance
- Exchange
- ASBP Nasdaq
- NYC Nasdaq
- Market Cap
- ASBP 26.6M
- NYC 28.8M
- IPO Year
- ASBP N/A
- NYC N/A
- Fundamental
- Price
- ASBP $0.51
- NYC $9.98
- Analyst Decision
- ASBP
- NYC
- Analyst Count
- ASBP 0
- NYC 0
- Target Price
- ASBP N/A
- NYC N/A
- AVG Volume (30 Days)
- ASBP 28.3M
- NYC 1.9K
- Earning Date
- ASBP 08-13-2025
- NYC 08-08-2025
- Dividend Yield
- ASBP N/A
- NYC N/A
- EPS Growth
- ASBP N/A
- NYC N/A
- EPS
- ASBP N/A
- NYC N/A
- Revenue
- ASBP N/A
- NYC $54,865,000.00
- Revenue This Year
- ASBP N/A
- NYC $8.40
- Revenue Next Year
- ASBP N/A
- NYC $1.62
- P/E Ratio
- ASBP N/A
- NYC N/A
- Revenue Growth
- ASBP N/A
- NYC N/A
- 52 Week Low
- ASBP $0.22
- NYC $7.89
- 52 Week High
- ASBP $15.80
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- ASBP 53.50
- NYC 34.32
- Support Level
- ASBP $0.52
- NYC $9.53
- Resistance Level
- ASBP $0.59
- NYC $10.96
- Average True Range (ATR)
- ASBP 0.09
- NYC 0.69
- MACD
- ASBP -0.00
- NYC -0.15
- Stochastic Oscillator
- ASBP 18.40
- NYC 14.55
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.